The human brain’s complexity makes it extremely challenging to study.
These factors may not be enough to finally end the Ebola epidemic in West Africa.
Patients with sickle cell disease often suffer from painful attacks known as vaso-occlusive crises, during which their sickle-shaped blood cells get stuck in tiny capillaries, depriving tissues of needed oxygen. Blood transfusions can sometimes prevent such attacks, but there are currently no good ways to predict when a vaso-occlusive crisis, which can last for several days, is imminent.
The focus of this department is to study the convergence of health and data.
These companies have an interesting year ahead of them.
In the midst of a worrisome flu season, health officials are pushing doctors to prescribe antiviral medicines more often.
The agreement will integrate genomics research conducted at Columbia with Biogen Idec’s understanding of disease mechanisms and pathways, and expertise in discovering new medicines.
23andMe and Genentech team up to generate whole genome sequencing data for approximately 3,000 people in 23andMe's Parkinson's disease community.
A small protein active in the human immune response can disable bacterial toxins by exploiting a property that makes the toxins effective.
Forgetfulness, it turns out, is all in the head. Scientists have shown that fading memory and clouding judgment, the type that comes with advancing age, show up as lost and altered connections between neurons in the brain. But new experiments suggest an existing drug, known as riluzole and already on the market as a treatment for ALS, may help prevent these changes.
It’s well known that chemotherapy helps fight cancer. It’s also known that it wreaks havoc on normal, healthy cells. Scientists are closer to discovering a possible way to boost healthy cell production in cancer patients as they receive chemotherapy.
Nitrous oxide, or laughing gas, has shown early promise as a potential treatment for severe depression in patients whose symptoms don’t respond to standard therapies.
Researchers have shown a non–surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3-D structure could fight and even help prevent cancer and also infectious disease such as HIV.
Forbes kicked off the 2014 Healthcare Summit with a session titled, “Drug Development in A Time of Ebola,” where Forbes senior editor Matthew Herper interviewed Edward Cox and Lucianna Borio, two high-ranking officials at the FDA.
Scientists have revealed how penicillin deals bacteria a devastating blow— which may lead to new ways to thwart drug resistance. Looking beyond penicillin’s known targets in the cell wall, the team showed that these drugs do more than simply block cell-wall assembly.
Take two poisonous mushrooms, and call me in the morning. While no doctor would ever write this prescription, toxic fungi may hold the secrets to tackling deadly diseases.
The flu vaccine may not be very effective this winter, according to U.S. health officials who worry this may lead to more serious illnesses and deaths.
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate.
A new hybrid vehicle is under development. Its performance isn’t measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, influenza and other maladies.
From new marijuana strains for the holidays to gift sets and pot-and-pumpkin pies, the burgeoning marijuana industry in Colorado is scrambling to get a piece of the holiday shopping dollar.
An interdisciplinary team of scientists has convened to map the origins of mental illnesses in the brain and develop noninvasive technologies to treat the conditions.
While the turkey you eat on Thursday will bring your stomach happiness and could probably kick-start an afternoon nap, it may also save your life one day.
Merck & Co., a top creator and seller of vaccines, has joined the fight against Ebola, the often-fatal hemorrhagic virus that's been ravaging parts of West Africa for months.
Guided by breakthrough research on the Estrogen Receptor 1 (ESR1) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug.
Research shows that taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward. The benefits seem to grow over time and may last for life.